Fundraising FoxVivaldi Biosciences
Fort Collins, US · 2 known investors
Find your way into Vivaldi Biosciences
Sign up to see every warm intro you have to Vivaldi Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vivaldi Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vivaldi Biosciences develops Delta NS1 vaccines designed to protect against epidemic and pandemic viral respiratory diseases. The company operates research operations in Colorado and Austria.
Founders & leadership
PP
Peter PaleseFounder & Scientific Advisor
AG
Adolfo García-SastreFounder & Scientific Advisor
EK
Elliott KieffFounder & Scientific Advisor
WW
William WickCEO, Board Member and Managing Director
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AJan 2009
Bay City Capital (lead), NGN Capital (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Vivaldi Biosciences do?
- Vivaldi Biosciences develops Delta NS1 vaccines designed to protect against epidemic and pandemic viral respiratory diseases. The company operates research operations in Colorado and Austria.
- Who founded Vivaldi Biosciences?
- Vivaldi Biosciences was founded by Peter Palese, Adolfo García-Sastre, Elliott Kieff.
- Who are Vivaldi Biosciences's investors?
- Vivaldi Biosciences's investors include NGN Capital, Bay City Capital.
- Where is Vivaldi Biosciences headquartered?
- Vivaldi Biosciences is headquartered in Fort Collins, US.